A single dose of zilebesiran 300 mg led to a 5-mmHg reduction in SBP at 3 months compared with the placebo, a difference that did not reach statistical significance.
← all excerpts
The evolving field of nephrology: what comes next? A report from the European Renal Association Scientific Advisory Board.
1
—
—